IRVINE,
Calif., March 21, 2024 /PRNewswire/ -- American
Healthcare REIT, Inc. (the "Company") (NYSE: AHR) announced today
its fourth quarter and full year 2023 results. Further, the Company
reported various subsequent-to-quarter-end items.
Key Highlights:
- Reported GAAP net loss attributable to stockholders of
$(0.42) and $(1.08) per basic and diluted share for the three
and 12 months ended December 31,
2023.
- Reported Normalized Funds from Operations attributable to
stockholders ("NFFO") of $0.38 and
$1.40 per basic and diluted share for
the three and 12 months ended December 31,
2023, respectively.
- Achieved 5.2% and 7.7% total portfolio Same-Store ("SS")
revenue growth for the three and 12 months ended December 31, 2023, respectively, compared to the
same periods in 2022 largely driven by occupancy gains in the
Company's RIDEA-operated assets.
- Achieved year-over-year total portfolio Same-Store Net
Operating Income ("NOI") growth of 8.6%, highlighted by 27.2% and
14.0% Same-Store NOI growth from our SHOP and Integrated Senior
Health Campuses ("ISHC"), respectively.
- Disposed of approximately $195
million of Non-Core Properties across the Company's
Outpatient Medical and SHOP segments during the 12 months ended
December 31, 2023.
- Subsequent to year end, completed a public offering of 64.4
million shares of our common stock priced at $12.00 per share and listed our common stock on
the New York Stock Exchange ("NYSE") under the symbol "AHR".
- Subsequent to year end, paid down approximately $721 million of outstanding debt obligations
carrying a weighted average interest rate of approximately 7.53%
using the net proceeds from the public offering, meaningfully
improving leverage metrics and providing the Company with
additional capacity and flexibility.
"We are proud of our 2023 operating results and have begun 2024
with a successful common stock offering and the listing of our
common stock on the NYSE. As a publicly listed company, we are
committed to being responsible stewards of capital for all our
stockholders. The entire team at American Healthcare REIT is
working diligently to ensure optimal performance across our entire
portfolio," said Danny Prosky,
American Healthcare REIT's President and CEO.
Fourth Quarter and Full-Year 2023 Results
"Our portfolio continues to recover since the onset of the
pandemic, with the trajectory of revenue growth drivers all heading
in the right direction. We have continued to see occupancy gains
since the end of 2023. Our unique investment in Integrated Senior
Health Campuses remains the most attractive part of our portfolio
with operating performance metrics such as occupancy already
surpassing pre-pandemic levels," said Gabe
Willhite, the Company's Chief Operating Officer.
SS NOI Growth Rates:
Quarter Ended December 31, 2023 Relative to Quarter Ended December
31, 2022
|
Metric
|
4Q 2023
Actual
|
ISHC
Outpatient
Medical
SHOP
Triple-Net
Leased
Total
Portfolio
|
13.9%
2.3%
44.9%
3.5%
9.5%
|
|
|
SS NOI Growth Rates:
Year Ended December 31, 2023 Relative to Year Ended December 31,
2022
|
Metric
|
FY 2023
Actual
|
ISHC
Outpatient
Medical
SHOP
Triple-Net
Leased
Total
Portfolio
|
14.0%
3.2%
27.2%
2.0%
8.6%
|
Same-Store revenue for our RIDEA-operated assets grew by 6.0%
and 8.9% during the three months and year ended December 31, 2023, respectively, compared to the
same periods in 2022. Expense growth across our SHOP assets has
moderated, partially due to recent operator transitions and
normalizing compensation expenses as a result of less agency-labor
usage across the portfolio. In aggregate, NOI growth remains well
above historical levels across the portfolio, as margin and
occupancy continue to recover from pandemic-era troughs.
Full Year 2024 Guidance
The Company has established the following guidance ranges for
the year ending December 31,
2024:
|
Full Year 2024
Guidance
|
Metric
|
FY 2023
Actual
|
FY 2024
Range
|
FY 2024
Midpoint
|
NAREIT FFO per
share
Normalized FFO per
share
Total Portfolio SS
NOI Growth:
|
$0.99
$1.40
8.6%
|
$1.13 to
$1.19
$1.18 to
$1.24
5.0% to 7.0%
|
$1.16
$1.21
6.0%
|
Certain of the
assumptions underlying the Company's 2024 outlook can be found
within the Non-GAAP reconciliations in this earnings release and in
the appendix of the Company's Fourth Quarter 2023 Supplemental
Financial Information ("Supplemental"). A reconciliation of Net
Loss calculated in accordance with GAAP to NAREIT FFO and NFFO can
be found within the Non-GAAP reconciliations in this earnings
release. Non-GAAP financial measures and other terms, as used in
this earnings release, are also defined and further explained in
the Supplemental. Within this release, we provide certain
forward-looking non-GAAP financial information, which management
uses for planning and measuring performance. We are not able to
reconcile forward-looking non-GAAP measures to reported measures
without unreasonable efforts because it is not possible to predict
with a reasonable degree of certainty the actual impact or exact
timing of items that may impact comparability throughout the
year.
|
"We believe 2024 should be another year of occupancy gains
within our SHOP segment that should support NOI growth and margin
expansion. Looking at our ISHC segment, we expect occupancy to
remain at or above pre-pandemic levels over the course of the year.
In aggregate, our guidance estimates another year of
mid-single-digit NOI growth across our entire diversified
healthcare portfolio," said Prosky.
Transactional Activity
During full year 2023, the Company completed a campus
acquisition and three lease buyouts within its ISHC segment for
total consideration of approximately $43.9
million, plus closing costs. We expect these acquisitions to
generate a yield on cost of approximately 9.0%.
During 2023, the Company sold 16 Non-Core outpatient medical
facilities and six Non-Core SHOP facilities generating
approximately $195 million in gross
proceeds.
Subsequent to quarter end, the Company continued to
opportunistically dispose of Non-Core assets, and has sold an
outpatient medical building in Marietta,
Georgia and a SHOP facility in Menlo Park, California for approximately
$11 million in aggregate gross
proceeds.
Additionally, as previously announced, on February 1, 2024, the Company closed on the
acquisition of a senior housing portfolio in Oregon consisting of 856 beds across 12
facilities. The total consideration consisted of $94.5 million of assumed debt, plus closing
costs, reflecting a price per bed of approximately $110,000. The assumed debt has a fixed interest
rate of 4.54% and matures on January 1,
2028. The portfolio will be managed by Compass Senior Living
through a RIDEA structure. The Company has a longstanding
relationship with Compass Senior Living as a tenant in our
triple-net leased segment and recognized the strength of the
operator through the COVID-19 pandemic. The management agreement
will be the Company's first with Compass Senior Living expanding
the Company's high-quality operator relationships.
Capital Markets and Balance Sheet Activity
On December 21, 2023, the Company
entered into a $200 million swap
agreement relating to debt at the ISHC portfolio, swapping SOFR for
a fixed rate of 4.40% on its variable-rate debt. This agreement was
effective as of January 5, 2024. The
Company now carries $750 million of
interest rate swap agreements fixing SOFR at a weighted average
interest rate of 4.16%.
Subsequent to quarter end, the Company completed a public
offering of 64.4 million shares of its common stock, raising gross
proceeds of $772.8 million, and
listed its common stock on the NYSE under the symbol "AHR".
This represented the largest REIT offering and listing event in the
US since 2018[1]. Net offering proceeds were used to pay down
approximately $721 million of
outstanding debt with a weighted average interest rate of 7.53%. As
previously announced, as of February 16,
2024, the Company had $747
million of outstanding balances on its lines of credit and
term loan, with a weighted average interest rate of 5.91% (taking
into account the effect of swap instruments), and $803 million of undrawn capacity under its lines
of credit and term loan. This significant reduction in outstanding
debt has resulted in an improvement in the Company's leverage by
meaningfully reducing near-term maturities and high-interest
floating-rate debt. In aggregate, the pay downs will result in
approximately $54 million in interest
expense savings on an annualized basis.
"After repaying approximately $721
million of indebtedness with the net proceeds from our
January 2024 public equity offering,
we estimate that we will be in the low 6x
net-debt-to-adjusted-EBITDA range at March
31, 2024. As we look ahead, we will maintain a conservative
approach to leverage, while being selective regarding external
growth opportunities. The offering and debt repayment were
transformative for our capital structure, and we believe that the
embedded growth within our SHOP and ISHC segments will allow our
leverage profile to continue to improve," said Brian Peay, the Company's Chief Financial
Officer.
Distribution
As previously announced, the Company's Board of Directors
declared a regular quarterly cash distribution for the quarter
ending March 31, 2024 of $0.25 per share of its common stock, Class T
common stock and Class I common stock. The distribution is payable
on or about April 19, 2024 to
stockholders of record as of the close of business on March 28, 2024.
Supplemental Information
The Company has disclosed supplemental information regarding its
portfolio, financial position and results of operations as of
December 31, 2023 and for the quarter
and year then ended, and certain other information, which is
available on the Company's website at
https://ir.americanhealthcarereit.com.
Conference Call and Webcast Information
The Company will host a webcast and conference call at
1:00 p.m. Eastern Time on
March 22, 2023. During the conference
call, Company executives will review fourth quarter and full year
2023 results, discuss recent events, and conduct a
question-and-answer period.
To join via webcast, investors may use the following link:
https://events.q4inc.com/attendee/923600160.
Alternatively, to join via telephone, please pre-register at the
following link using the Conference ID 66737.
A digital replay of the call will be available on our website at
https://ir.americanhealthcarereit.com shortly after the conclusion
of the call.
Forward-Looking Statements
Certain statements contained in this press release, including
statements relating to the Company's expectations regarding its
portfolio growth, interest expense savings, balance sheet, net
income or loss per share, FFO per share, NFFO per share, total
portfolio Same-Store NOI growth, occupancy, NOI growth, revenue
growth and margin expansion may be considered forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. The Company intends for all such
forward-looking statements to be covered by the applicable safe
harbor provisions for forward-looking statements contained in those
acts. Such forward-looking statements generally can be identified
by the use of forward-looking terminology such as "may," "will,"
"can," "expect," "intend," "anticipate," "estimate," "believe,"
"continue," "possible," "initiatives," "focus," "seek,"
"objective," "goal," "strategy," "plan," "potential,"
"potentially," "preparing," "projected," "future," "long-term,"
"once," "should," "could," "would," "might," "uncertainty," or
other similar words. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Any such forward-looking
statements are based on current expectations, estimates and
projections about the industry and markets in which the Company
operates, and beliefs of, and assumptions made by, the Company's
management and involve known and unknown risks and uncertainties
that could cause actual results to differ materially from those
expressed or implied therein, including, without limitation, risks
disclosed in the Company's periodic reports filed with the
Securities and Exchange Commission. Except as required by law, the
Company does not undertake any obligation to update or revise any
forward-looking statements contained in this release.
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. is a self-managed real estate
investment trust that acquires, owns and operates a diversified
portfolio of clinical healthcare real estate properties, focusing
primarily on outpatient medical buildings, senior housing, skilled
nursing facilities and other healthcare-related facilities. Its
properties are located in 36 states, the United Kingdom and the Isle of Man. For additional information,
please visit www.AmericanHealthcareREIT.com.
|
|
|
|
|
|
|
|
|
1Per NAREIT
based on data available since 2000, which can be found at:
https://www.reit.com/data-research/reit-market-data/reit-capital-offerings
|
AMERICAN HEALTHCARE
REIT, INC.
CONSOLIDATED BALANCE
SHEETS
As of December 31,
2023 and 2022
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
December
31,
|
|
2023
|
|
2022
|
ASSETS
|
Real estate
investments, net
|
$
3,425,438
|
|
$
3,581,609
|
Debt security
investment, net
|
86,935
|
|
83,000
|
Cash and cash
equivalents
|
43,445
|
|
65,052
|
Restricted
cash
|
47,337
|
|
46,854
|
Accounts and other
receivables, net
|
185,379
|
|
137,501
|
Identified intangible
assets, net
|
180,470
|
|
236,283
|
Goodwill
|
234,942
|
|
231,611
|
Operating lease
right-of-use assets, net
|
227,846
|
|
276,342
|
Other assets,
net
|
146,141
|
|
128,446
|
Total
assets
|
$
4,577,933
|
|
$
4,786,698
|
|
|
|
|
LIABILITIES,
REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
|
Liabilities:
|
|
|
|
Mortgage loans
payable, net
|
$
1,302,396
|
|
$
1,229,847
|
Lines of credit and
term loan, net
|
1,223,967
|
|
1,281,794
|
Accounts payable and
accrued liabilities
|
242,905
|
|
243,831
|
Identified intangible
liabilities, net
|
6,095
|
|
10,837
|
Financing
obligations
|
41,756
|
|
48,406
|
Operating lease
liabilities
|
225,502
|
|
273,075
|
Security deposits,
prepaid rent and other liabilities
|
76,134
|
|
49,545
|
Total
liabilities
|
3,118,755
|
|
3,137,335
|
|
|
|
|
Redeemable
noncontrolling interests
|
33,843
|
|
81,598
|
|
|
|
|
Equity:
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred stock,
$0.01 par value per share; 200,000,000 shares authorized;
none
issued and outstanding
|
—
|
|
—
|
Class T common stock,
$0.01 par value per share; 200,000,000 shares
authorized;
19,552,856 and 19,535,095 shares issued and
outstanding as of December 31,
2023 and 2022, respectively
|
194
|
|
194
|
Class I common stock,
$0.01 par value per share; 800,000,000 shares
authorized;
46,673,320 and 46,675,367 shares issued and
outstanding as of December 31,
2023 and 2022, respectively
|
467
|
|
467
|
Additional paid-in
capital
|
2,548,307
|
|
2,540,424
|
Accumulated
deficit
|
(1,276,222)
|
|
(1,138,304)
|
Accumulated other
comprehensive loss
|
(2,425)
|
|
(2,690)
|
Total stockholders'
equity
|
1,270,321
|
|
1,400,091
|
Noncontrolling
interests
|
155,014
|
|
167,674
|
Total
equity
|
1,425,335
|
|
1,567,765
|
Total liabilities,
redeemable noncontrolling interests and equity
|
$
4,577,933
|
|
$
4,786,698
|
AMERICAN HEALTHCARE
REIT, INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
For the Years Ended
December 31, 2023, 2022 and 2021
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
Years Ended December
31,
|
|
2023
|
|
2022
|
|
2021
|
Revenues and grant
income:
|
|
|
|
|
|
Resident fees and
services
|
$
1,668,742
|
|
$
1,412,156
|
|
$
1,123,935
|
Real estate
revenue
|
190,401
|
|
205,344
|
|
141,368
|
Grant
income
|
7,475
|
|
25,675
|
|
16,951
|
Total revenues and
grant income
|
1,866,618
|
|
1,643,175
|
|
1,282,254
|
Expenses:
|
|
|
|
|
|
Property operating
expenses
|
1,502,310
|
|
1,281,526
|
|
1,030,193
|
Rental
expenses
|
57,475
|
|
59,684
|
|
38,725
|
General and
administrative
|
47,510
|
|
43,418
|
|
43,199
|
Business acquisition
expenses
|
5,795
|
|
4,388
|
|
13,022
|
Depreciation and
amortization
|
182,604
|
|
167,957
|
|
133,191
|
Total
expenses
|
1,795,694
|
|
1,556,973
|
|
1,258,330
|
Other income
(expense):
|
|
|
|
|
|
Interest
expense:
|
|
|
|
|
|
Interest expense
(including amortization of deferred financing costs,
debt discount/premium and loss on
debt extinguishments)
|
(163,191)
|
|
(105,956)
|
|
(80,937)
|
(Loss) gain in fair
value of derivative financial instruments
|
(926)
|
|
500
|
|
8,200
|
Gain (loss) on
dispositions of real estate investments, net
|
32,472
|
|
5,481
|
|
(100)
|
Impairment of real
estate investments
|
(13,899)
|
|
(54,579)
|
|
(3,335)
|
Impairment of
intangible assets and goodwill
|
(10,520)
|
|
(23,277)
|
|
—
|
(Loss) income from
unconsolidated entities
|
(1,718)
|
|
1,407
|
|
(1,355)
|
Gain on re-measurement
of previously held equity interests
|
726
|
|
19,567
|
|
—
|
Foreign currency gain
(loss)
|
2,307
|
|
(5,206)
|
|
(564)
|
Other
income
|
7,601
|
|
3,064
|
|
1,854
|
Total net other
expense
|
(147,148)
|
|
(158,999)
|
|
(76,237)
|
Loss before income
taxes
|
(76,224)
|
|
(72,797)
|
|
(52,313)
|
Income tax
expense
|
(663)
|
|
(586)
|
|
(956)
|
Net
loss
|
(76,887)
|
|
(73,383)
|
|
(53,269)
|
Net loss (income)
attributable to noncontrolling interests
|
5,418
|
|
(7,919)
|
|
5,475
|
Net loss
attributable to controlling interest
|
$
(71,469)
|
|
$
(81,302)
|
|
$
(47,794)
|
Net loss per Class T
and Class I common share attributable to controlling
interest — basic and diluted
|
$
(1.08)
|
|
$
(1.24)
|
|
$
(0.95)
|
Weighted average
number of Class T and Class I common shares outstanding
— basic and diluted
|
66,047,114
|
|
65,807,868
|
|
50,081,140
|
|
|
|
|
|
|
Net loss
|
$
(76,887)
|
|
$
(73,383)
|
|
$
(53,269)
|
Other comprehensive
income (loss):
|
|
|
|
|
|
Foreign currency
translation adjustments
|
265
|
|
(724)
|
|
(65)
|
Total other
comprehensive income (loss)
|
265
|
|
(724)
|
|
(65)
|
Comprehensive
loss
|
(76,622)
|
|
(74,107)
|
|
(53,334)
|
Comprehensive loss
(income) attributable to noncontrolling interests
|
5,418
|
|
(7,919)
|
|
5,582
|
Comprehensive loss
attributable to controlling interest
|
$
(71,204)
|
|
$
(82,026)
|
|
$
(47,752)
|
AMERICAN HEALTHCARE
REIT, INC.
FFO and Normalized
FFO Reconciliation
For the Years Ended
December 31, 2023, 2022 and 2021
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
Years Ended December
31,
|
|
2023
|
|
2022
|
|
2021
|
Net loss
|
$
(76,887)
|
|
$
(73,383)
|
|
$
(53,269)
|
Depreciation and
amortization related to real estate — consolidated
properties
|
182,452
|
|
167,860
|
|
133,191
|
Depreciation and
amortization related to real estate — unconsolidated
entities
|
401
|
|
1,102
|
|
3,116
|
Impairment of real
estate investments — consolidated properties
|
13,899
|
|
54,579
|
|
3,335
|
(Gain) loss on
dispositions of real estate investments, net — consolidated
properties
|
(32,472)
|
|
(5,481)
|
|
100
|
Net loss (income)
attributable to noncontrolling interests
|
5,418
|
|
(7,919)
|
|
5,475
|
Gain on re-measurement
of previously held equity interests
|
(726)
|
|
(19,567)
|
|
—
|
Depreciation,
amortization, impairments, net gain/loss on dispositions and gain
on
re-measurements — noncontrolling
interests
|
(26,518)
|
|
(22,614)
|
|
(22,270)
|
NAREIT FFO attributable
to controlling interest
|
$
65,567
|
|
$
94,577
|
|
$
69,678
|
|
|
|
|
|
|
Business acquisition
expenses
|
$
5,795
|
|
$
4,388
|
|
$
13,022
|
Amortization of above-
and below-market leases
|
9,744
|
|
2,596
|
|
953
|
Amortization of closing
costs — debt security investments
|
278
|
|
237
|
|
201
|
Change in deferred
rent
|
1,149
|
|
(3,355)
|
|
(20)
|
Non-cash impact of
changes to equity instruments
|
5,621
|
|
3,909
|
|
1,008
|
Capitalized
interest
|
(163)
|
|
(150)
|
|
(628)
|
Loss on debt
extinguishments
|
345
|
|
5,166
|
|
2,655
|
Loss (gain) in fair
value of derivative financial instruments
|
926
|
|
(500)
|
|
(8,200)
|
Foreign currency (gain)
loss
|
(2,307)
|
|
5,206
|
|
564
|
Impairment of
intangible assets and goodwill
|
10,520
|
|
23,277
|
|
—
|
Adjustments for
unconsolidated entities
|
(321)
|
|
113
|
|
573
|
Adjustments for
noncontrolling interests
|
(4,786)
|
|
(3,530)
|
|
(1,653)
|
Normalized FFO
attributable to controlling interest
|
$
92,368
|
|
$
131,934
|
|
$
78,153
|
Weighted average Class
T and Class I common shares outstanding — basic and
diluted
|
66,047,114
|
|
65,807,868
|
|
50,081,140
|
Net loss per Class T
and Class I common share attributable to controlling interest
— basic and diluted
|
$
(1.08)
|
|
$
(1.24)
|
|
$
(0.95)
|
NAREIT FFO per Class T
and Class I common share attributable to controlling interest
— basic and diluted
|
$
0.99
|
|
$
1.44
|
|
$
1.39
|
Normalized FFO per
Class T and Class I common share attributable to controlling
interest — basic and diluted
|
$
1.40
|
|
$
2.00
|
|
$
1.56
|
AMERICAN HEALTHCARE
REIT, INC.
FFO and Normalized
FFO Reconciliation
For the Three Months
Ended December 31, 2023 and 2022
(In thousands,
except share and per share amounts) (Unaudited)
|
|
|
Three Months Ended
December 31,
|
|
2023
|
|
2022
|
Net loss
|
$
(30,959)
|
|
$
(49,300)
|
Depreciation and
amortization related to real estate — consolidated properties
|
43,922
|
|
45,220
|
Depreciation and
amortization related to real estate — unconsolidated entities
|
147
|
|
59
|
Impairment of real
estate investments — consolidated properties
|
1,389
|
|
15,388
|
Gain on dispositions of
real estate investments, net — consolidated properties
|
(2,695)
|
|
(2,685)
|
Net loss attributable
to noncontrolling interests
|
3,534
|
|
1,769
|
Depreciation,
amortization, impairments, net gain on dispositions
— noncontrolling
interests
|
(6,846)
|
|
(7,704)
|
NAREIT FFO attributable
to controlling interest
|
$
8,492
|
|
$
2,747
|
|
|
|
|
Business acquisition
expenses
|
$
3,551
|
|
$
2,227
|
Amortization of above-
and below-market leases
|
(2,489)
|
|
692
|
Amortization of closing
costs – debt security investments
|
74
|
|
63
|
Change in deferred
rent
|
(89)
|
|
(22)
|
Non-cash impact of
changes to equity instruments
|
1,377
|
|
1,250
|
Capitalized
interest
|
(36)
|
|
(28)
|
Loss on debt
extinguishments
|
—
|
|
128
|
Loss in fair value of
derivative financial instruments
|
9,126
|
|
—
|
Foreign currency
gain
|
(1,935)
|
|
(3,483)
|
Impairment of
intangible assets and goodwill
|
10,520
|
|
23,277
|
Adjustments for
unconsolidated entities
|
38
|
|
(49)
|
Adjustments for
noncontrolling interests
|
(3,810)
|
|
(1,452)
|
Normalized FFO
attributable to controlling interest
|
$
24,819
|
|
$
25,350
|
Weighted average Class
T and Class I common shares outstanding — basic and diluted
|
66,079,343
|
|
66,023,570
|
Net loss per Class T
and Class I common share attributable to controlling
interest — basic and diluted
|
$
(0.42)
|
|
$
(0.72)
|
NAREIT FFO per Class T
and Class I common share attributable to controlling interest — basic and diluted
|
$
0.13
|
|
$
0.04
|
Normalized FFO per
Class T and Class I common share attributable to
controlling interest — basic and
diluted
|
$
0.38
|
|
$
0.38
|
AMERICAN HEALTHCARE
REIT, INC.
Cash NOI
Reconciliation
For the Three Months
Ended and Years Ended December 31, 2023 and 2022
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
December 31,
|
|
Year Ended December
31,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
Net loss
|
$
(30,959)
|
|
$
(49,300)
|
|
$
(76,887)
|
|
$
(73,383)
|
General and
administrative
|
11,341
|
|
11,745
|
|
47,510
|
|
43,418
|
Business acquisition
expenses
|
3,551
|
|
2,227
|
|
5,795
|
|
4,388
|
Depreciation and
amortization
|
43,960
|
|
45,253
|
|
182,604
|
|
167,957
|
Interest
expense
|
41,185
|
|
34,762
|
|
163,191
|
|
105,956
|
Loss (gain) in fair
value of derivative financial instrument
|
9,126
|
|
—
|
|
926
|
|
(500)
|
Gain on dispositions of
real estate investments
|
(2,695)
|
|
(2,685)
|
|
(32,472)
|
|
(5,481)
|
Impairment of real
estate investments
|
1,389
|
|
15,388
|
|
13,899
|
|
54,579
|
Impairment of
intangible assets and goodwill
|
10,520
|
|
23,277
|
|
10,520
|
|
23,277
|
Loss (income) from
unconsolidated entities
|
794
|
|
273
|
|
1,718
|
|
(1,407)
|
Gain on re-measurement
of previously held equity interest
|
—
|
|
—
|
|
(726)
|
|
(19,567)
|
Foreign currency (gain)
loss
|
(1,935)
|
|
(3,483)
|
|
(2,307)
|
|
5,206
|
Other income
|
(1,649)
|
|
(665)
|
|
(7,601)
|
|
(3,064)
|
Income tax (benefit)
expense
|
(112)
|
|
87
|
|
663
|
|
586
|
Total NOI
|
$
84,516
|
|
$
76,879
|
|
$
306,833
|
|
$
301,965
|
|
|
|
|
|
|
|
|
Grant Income
|
(30)
|
|
(2,959)
|
|
(7,475)
|
|
(25,675)
|
Total NOI (excluding
Grant Income)
|
$
84,486
|
|
$
73,920
|
|
$
299,358
|
|
$
276,290
|
|
|
|
|
|
|
|
|
Straight line
rent
|
(584)
|
|
(1,110)
|
|
(3,481)
|
|
(6,522)
|
Facility rental
expense
|
8,774
|
|
9,248
|
|
37,025
|
|
25,155
|
Other non-cash
adjustments
|
(2,397)
|
|
714
|
|
9,946
|
|
3,052
|
COVID
subsidy
|
—
|
|
—
|
|
(171)
|
|
—
|
Consolidated Cash
NOI
|
$
90,279
|
|
$
82,772
|
|
$
342,677
|
|
$
297,975
|
|
|
|
|
|
|
|
|
Cash NOI attributable
to noncontrolling interests (1)
|
(13,439)
|
|
(11,804)
|
|
(48,724)
|
|
(39,084)
|
Pro-Rata Cash
NOI
|
$
76,840
|
|
$
70,968
|
|
$
293,953
|
|
$
258,891
|
|
|
|
|
|
|
(1)
|
All quarters are based
upon current quarter's ownership percentage.
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store NOI
Reconciliation
For the Three Months
Ended and Years Ended December 31, 2023 and 2022
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
December 31,
|
|
Year Ended December
31,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
ISHC
|
|
|
|
|
|
|
|
Cash NOI
|
$
37,431
|
|
$
32,859
|
|
$
135,598
|
|
$
108,376
|
New
acquisitions/dispositions/transitions
|
(12,385)
|
|
(10,872)
|
|
(46,204)
|
|
(29,943)
|
Same-Store
NOI
|
$
25,046
|
|
$
21,987
|
|
$
89,394
|
|
$
78,433
|
|
|
|
|
|
|
|
|
Outpatient
Medical
|
|
|
|
|
|
|
|
Cash NOI
|
$
20,813
|
|
$
22,558
|
|
$
87,993
|
|
$
89,807
|
New
acquisitions/dispositions/transitions
|
(1)
|
|
(2,205)
|
|
(4,643)
|
|
(9,028)
|
Other normalizing
adjustments
|
—
|
|
—
|
|
—
|
|
(39)
|
Same-Store
NOI
|
$
20,812
|
|
$
20,353
|
|
$
83,350
|
|
$
80,740
|
|
|
|
|
|
|
|
|
SHOP
|
|
|
|
|
|
|
|
Cash NOI
|
$
6,461
|
|
$
2,684
|
|
$
20,045
|
|
$
9,358
|
New
acquisitions/dispositions/transitions
|
(2,336)
|
|
184
|
|
(3,793)
|
|
3,760
|
Non-Core
Properties
|
115
|
|
176
|
|
242
|
|
831
|
Other normalizing
adjustments
|
171
|
|
—
|
|
758
|
|
(387)
|
Same-Store
NOI
|
$
4,411
|
|
$
3,044
|
|
$
17,252
|
|
$
13,562
|
|
|
|
|
|
|
|
|
Triple-Net Leased
Properties
|
|
|
|
|
|
|
|
Cash NOI
|
$
12,135
|
|
$
12,867
|
|
$
50,317
|
|
$
51,350
|
Debt security
investment
|
(2,011)
|
|
(1,944)
|
|
(8,040)
|
|
(7,818)
|
New
acquisitions/dispositions/transitions
|
(545)
|
|
(1,668)
|
|
(4,541)
|
|
(6,542)
|
Same-Store
NOI
|
$
9,579
|
|
$
9,255
|
|
$
37,736
|
|
$
36,990
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
Cash NOI
|
$
76,840
|
|
$
70,968
|
|
$
293,953
|
|
$
258,891
|
Debt security
investment
|
(2,011)
|
|
(1,944)
|
|
(8,040)
|
|
(7,818)
|
New
acquisitions/dispositions/transitions
|
(15,267)
|
|
(14,561)
|
|
(59,181)
|
|
(41,753)
|
Non-Core
Properties
|
115
|
|
176
|
|
242
|
|
831
|
New
acquisitions/dispositions/transitions
|
171
|
|
—
|
|
758
|
|
(426)
|
Same-Store
NOI
|
$
59,848
|
|
$
54,639
|
|
$
227,732
|
|
$
209,725
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store Revenue
Reconciliation
For the Three Months
Ended and Years Ended December 31, 2023 and 2022
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
December 31,
|
|
Year Ended December
31,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
ISHC
|
|
|
|
|
|
|
|
GAAP revenue and Grant
Income
|
$
384,993
|
|
$
360,279
|
|
$
1,489,355
|
|
$
1,279,485
|
Grant Income
|
(30)
|
|
(2,959)
|
|
(7,475)
|
|
(24,820)
|
Cash revenue
attributable to noncontrolling interest (1)
|
(99,846)
|
|
(92,675)
|
|
(384,347)
|
|
(325,416)
|
Cash revenue
|
285,117
|
|
264,645
|
|
1,097,533
|
|
929,249
|
Revenue attributable to
non-Same-Store properties
|
(135,193)
|
|
(123,135)
|
|
(516,746)
|
|
(400,298)
|
Same-Store
revenue
|
$
149,924
|
|
$
141,510
|
|
$
580,787
|
|
$
528,951
|
|
|
|
|
|
|
|
|
Outpatient
Medical
|
|
|
|
|
|
|
|
GAAP revenue
|
$
36,257
|
|
$
36,919
|
|
$
146,068
|
|
$
148,717
|
Straight line
rent
|
(291)
|
|
(382)
|
|
(1,320)
|
|
(3,292)
|
Other non-cash
adjustments
|
(2,995)
|
|
(113)
|
|
(3,349)
|
|
(469)
|
Cash revenue
attributable to noncontrolling interest (1)
|
(156)
|
|
(139)
|
|
(592)
|
|
(535)
|
Cash revenue
|
32,815
|
|
36,285
|
|
140,807
|
|
144,421
|
Revenue attributable to
non-Same-Store properties
|
(32)
|
|
(3,914)
|
|
(8,201)
|
|
(15,886)
|
Other normalizing
revenue adjustments
|
—
|
|
—
|
|
—
|
|
(104)
|
Same-Store
revenue
|
$
32,783
|
|
$
32,371
|
|
$
132,606
|
|
$
128,431
|
|
|
|
|
|
|
|
|
SHOP
|
|
|
|
|
|
|
|
GAAP revenue and Grant
Income
|
$
48,321
|
|
$
41,331
|
|
$
186,862
|
|
$
158,346
|
Grant Income
|
—
|
|
—
|
|
—
|
|
(855)
|
Cash revenue
attributable to noncontrolling interest (1)
|
(271)
|
|
(409)
|
|
(1,287)
|
|
(1,612)
|
Cash revenue
|
48,050
|
|
40,922
|
|
185,575
|
|
155,879
|
Revenue attributable to
non-Same-Store properties
|
(14,059)
|
|
(9,212)
|
|
(53,624)
|
|
(30,983)
|
Revenue attributable to
Non-Core Properties
|
(539)
|
|
(285)
|
|
(1,923)
|
|
(934)
|
Other normalizing
revenue adjustments
|
—
|
|
—
|
|
(30)
|
|
66
|
Same-Store
revenue
|
$
33,452
|
|
$
31,425
|
|
$
129,998
|
|
$
124,028
|
|
|
|
|
|
|
|
|
Triple-Net Leased
Properties
|
|
|
|
|
|
|
|
GAAP revenue
|
$
13,010
|
|
$
14,054
|
|
$
44,333
|
|
$
56,627
|
Straight line
rent
|
(293)
|
|
(728)
|
|
(2,161)
|
|
(3,230)
|
Other non-cash
adjustments
|
206
|
|
460
|
|
11,833
|
|
1,820
|
Cash revenue
attributable to noncontrolling interest (1)
|
(186)
|
|
(181)
|
|
(738)
|
|
(720)
|
Cash revenue
|
12,737
|
|
13,605
|
|
53,267
|
|
54,497
|
Debt security
investment
|
(2,011)
|
|
(1,944)
|
|
(8,040)
|
|
(7,818)
|
Revenue attributable to
non-Same-Store properties
|
(572)
|
|
(1,891)
|
|
(5,113)
|
|
(7,251)
|
Other normalizing
revenue adjustments
|
—
|
|
—
|
|
—
|
|
(178)
|
Same-Store
revenue
|
$
10,154
|
|
$
9,770
|
|
$
40,114
|
|
$
39,250
|
AMERICAN HEALTHCARE
REIT, INC.
Same-Store Revenue
Reconciliation
For the Three Months
Ended and Years Ended December 31, 2023 and 2022
(In thousands)
(Unaudited)
|
|
|
Three Months Ended
December 31,
|
|
Year Ended December
31,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
Total
|
|
|
|
|
|
|
|
GAAP revenue and Grant
Income
|
$
482,581
|
|
$
452,583
|
|
$
1,866,618
|
|
$
1,643,175
|
Straight line
rent
|
(584)
|
|
(1,110)
|
|
(3,481)
|
|
(6,522)
|
Other non-cash
adjustments
|
(2,789)
|
|
347
|
|
8,484
|
|
1,351
|
Grant Income
|
(30)
|
|
(2,959)
|
|
(7,475)
|
|
(25,675)
|
Cash revenue
attributable to noncontrolling interest (1)
|
(100,459)
|
|
(93,404)
|
|
(386,964)
|
|
(328,283)
|
Cash revenue
|
378,719
|
|
355,457
|
|
1,477,182
|
|
1,284,046
|
Debt security
investment
|
(2,011)
|
|
(1,944)
|
|
(8,040)
|
|
(7,818)
|
Revenue attributable to
non-Same-Store properties
|
(149,856)
|
|
(138,152)
|
|
(583,684)
|
|
(454,418)
|
Revenue attributable to
Non-Core Properties
|
(539)
|
|
(285)
|
|
(1,923)
|
|
(934)
|
Other normalizing
revenue adjustments
|
—
|
|
—
|
|
(30)
|
|
(216)
|
Same-Store
revenue
|
$
226,313
|
|
$
215,076
|
|
$
883,505
|
|
$
820,660
|
|
|
|
|
|
|
(1)
|
All quarters are based
upon current quarter's ownership percentage.
|
AMERICAN HEALTHCARE
REIT, INC.
Earnings Outlook
Reconciliation
For the Year Ending
December 31, 2024
(In millions, except
per share amounts) (Unaudited)
|
|
|
Low
|
|
High
|
Net (loss) income
attributable to common stockholders
|
$
(4.15)
|
|
$
3.19
|
Depreciation and
amortization(1)
|
147.26
|
|
147.26
|
NAREIT FFO attributable
to common stockholders
|
$ 143.11
|
|
$
150.45
|
|
|
|
|
Amortization other
intangible assets(1)
|
$
1.66
|
|
$
1.66
|
Change in deferred
rent(1)
|
(0.42)
|
|
(0.42)
|
Non-cash impact of
changes to equity plan(1)
|
6.04
|
|
6.04
|
Other
adjustments
|
(0.80)
|
|
(0.80)
|
Normalized FFO
attributable to common stockholders
|
$
149.58
|
|
$
156.92
|
|
|
|
|
NAREIT FFO per
common share
|
$
1.13
|
|
$
1.19
|
|
|
|
|
Normalized FFO
per common share
|
$
1.18
|
|
$
1.24
|
|
|
|
|
Total Portfolio
Same-Store NOI growth
|
5.00 %
|
|
7.00 %
|
|
|
|
|
|
|
|
|
(1)
|
Amounts presented net
of noncontrolling interests' share and AHR's share of
unconsolidated entities.
|
|
|
|
The Company does not
provide guidance for the most comparable GAAP financial measures of
total revenues and property operating and maintenance expenses.
Additionally, a reconciliation of the forward-looking non-GAAP
financial measures of Same-Store NOI growth to the comparable GAAP
financial measures cannot be provided without unreasonable effort
because the Company is unable to reasonably predict certain items
contained in the GAAP measures, including non-recurring and
infrequent items that are not indicative of the Company's ongoing
operations. Such items include, but are not limited to, impairment
on depreciated real estate assets, net (gain)/loss on sale of
previously depreciated real estate assets, stock-based
compensation, casualty loss, non-Same-Store revenues, and
non-Same-Store operating expenses. These items are uncertain,
depend on various factors, and could have a material impact on the
Company's GAAP results for the guidance period.
|
Definitions
Adjusted EBITDA: Adjusted EBITDA is defined as
EBITDA excluding the impact of stock-based compensation expense,
acquisition and pursuit costs, gain (loss) on sales of real estate,
unrealized foreign currency gain (loss), change in fair value of
financial instruments, impairment of real estate assets, lease
termination revenue, non-recurring items, and adjusted for
non-controlling interest.
Affiliated: means an OM (as defined on the next page)
that, as of a specified date, has 25.0% or more of its square
footage occupied by at least one healthcare system.
AL: refers to assisted living units.
Annualized Adjusted EBITDA: current period (shown as
quarterly) EBITDA multiplied by 4.
Annualized Base Rent or ABR: contractual base rent for
the last month of the applicable period multiplied by 12.
Cash NOI: Cash NOI is defined as NOI but excluding the
impact of, without duplication, (1) non-cash items such as
straight-line rent and the amortization of lease intangibles, (2)
third party facility rent payments and (3) other items set forth in
the Cash NOI reconciliation included herein. Both Cash NOI and
Same-Store NOI include ownership and other adjustments.
EBITDA: EBITDA is a non-GAAP financial measure that is
defined as earnings before interest, taxes, depreciation, and
amortization.
EBITDAR: Earnings before interest, taxes, depreciation,
amortization and facilities rent. We use unaudited, periodic
financial information provided solely by tenants to calculate
EBITDAR and have not independently verified the information.
EBITDAR Coverage: represents the ratio of EBITDAR to
contractual rent for leases or interest and principal payments for
loans. EBITDAR Coverage is a measure of a property's ability to
generate sufficient cash flows for the operator/borrower to pay
rent and meet other obligations.
EBITDARM: Earnings before interest, taxes,
depreciation, amortization, rent and management fees. We use
unaudited, periodic financial information provided solely by
tenants to calculate EBITDARM and have not independently verified
the information.
EBITDARM Coverage: represents the ratio of EBITDARM to
contractual rent for leases or interest and principal payments for
loans. EBITDARM coverage is a measure of a property's ability to
generate sufficient cash flows for the operator/borrower to pay
rent and meet other obligations, assuming that management fees are
not paid.
GAAP revenue: revenue recognized in accordance with
Generally Accepted Accounting Principles ("GAAP"), which includes
straight line rent and other non-cash adjustments.
GLA: gross leasable area.
Grant Income: stimulus funds granted to us through
various federal and state government programs, such as the CARES
Act, established for eligible healthcare providers to preserve
liquidity in response to lost revenues and/or increased healthcare
expenses associated with the COVID-19 pandemic; such grants are not
loans and, as such, are not required to be repaid, subject to
certain conditions.
Hospital: hospital properties typically will include
acute care, long term acute care, specialty and rehabilitation
hospitals and generally will be leased to single tenants or
operators under triple-net lease structures.
IL: refers to independent living units.
Integrated senior health campuses or ISHC: Integrated
senior health campuses include a range of senior care, including
independent living, assisted living, memory care, skilled nursing
services, and certain ancillary businesses. Integrated Senior
Health Campuses are predominantly operated utilizing a RIDEA
structure.
Maintenance Capex: AHR-invested capital expenditures,
whether routine or non-routine (including second generation tenant
incentives and leasing commissions), that extend the useful life of
a property but are not expected to generate incremental income for
the Company.
MC: refers to memory-care units.
NAREIT FFO or FFO: funds from operations attributable
to controlling interest is a non-GAAP financial measure, consistent
with the standards established by the White Paper on FFO approved
by the Board of Governors of NAREIT (the "White Paper"). The White
Paper defines FFO as net income (loss) computed in accordance with
GAAP, excluding gains or losses from sales of certain real estate
assets, gains or losses upon consolidation of a previously held
equity interest, and impairment write downs of certain real estate
assets and investments, plus depreciation and amortization related
to real estate, and after adjustments for unconsolidated
partnerships and joint ventures. While impairment charges are
excluded from the calculation of FFO as described above, investors
are cautioned that impairments are based on estimated future
undiscounted cash flows. Adjustments for unconsolidated
partnerships and joint ventures are calculated to reflect FFO.
NAV: Net asset value.
Net Debt: Total long-term debt, excluding operating
lease liabilities, less cash and cash equivalents and restricted
cash pertaining to debt.
NOI: Net operating income is a non-GAAP financial
measure that is defined as net income (loss), computed in
accordance with GAAP, generated from properties before general and
administrative expenses, business acquisition expenses,
depreciation and amortization, interest expense, gain or loss on
dispositions, impairment of real estate investments, impairment of
goodwill, income or loss from unconsolidated entities, gain on
re-measurement of previously held equity interest, foreign currency
gain or loss, other income, and income tax benefit or expense.
Non-Core Properties: assets that have been deemed not
essential to generating future economic benefit or values to our
day-to-day operations and/or are scheduled for closure or to be
sold.
Normalized FFO attributable to controlling interest or
NFFO: Normalized FFO attributable to controlling interest
is defined as FFO further adjusted for the following items included
in the determination of GAAP net income (loss): expensed
acquisition fees and costs, which we refer to as business
acquisition expenses; amounts relating to changes in deferred rent
and amortization of above and below-market leases (which are
adjusted in order to reflect such payments from a GAAP accrual
basis); the non-cash impact of changes to our equity instruments;
non-cash or non-recurring income or expense; the noncash effect of
income tax benefits or expenses; capitalized interest; impairment
of goodwill; amortization of closing costs on debt investments;
mark-to-market adjustments included in net income (loss); gains or
losses included in net income (loss) from the extinguishment or
sale of debt, hedges, foreign exchange, derivatives or securities
holdings where trading of such holdings is not a fundamental
attribute of the business plan; and after adjustments for
consolidated and unconsolidated partnerships and joint ventures,
with such adjustments calculated to reflect Normalized FFO on the
same basis.
Occupancy: OM occupancy represents the percentage of
total rentable square feet leased and occupied, including
month-to-month leases, as of the date reported. Occupancy for all
other property types represents average quarterly operating
occupancy based on the most recent quarter of available data. The
company uses unaudited, periodic financial information provided
solely by tenants to calculate occupancy and has not independently
verified the information. Occupancy metrics are reflected at our
pro rata share.
OM: Outpatient Medical Buildings.
OP unit: units of limited partnership interest in the
Operating Partnership, which are redeemable for cash or, at our
election, shares of our common stock on a one-for-one basis,
subject to certain adjustments.
Operating Partnership: means American Healthcare REIT
Holdings, LP, a Delaware limited
partnership, through which we conduct substantially all of our
business and of which Continental Merger Sub, LLC, a Delaware limited liability company and our
wholly-owned subsidiary, is the sole general partner.
Pro-Rata: As of December 31,
2023, we owned and/or operated our 125 integrated senior
health campuses through entities of which we owned 74.1% of the
ownership interests and 10 other buildings through entities of
which we owned 86.0% to 98.0% of the ownership interests. Because
we have a controlling interest in these entities, these entities
and the properties these entities own are consolidated in our
financial statements in accordance with GAAP. However, while such
properties are presented in our financial statements on a
consolidated basis, we are only entitled to our pro rata share of
the net cash flows generated by such properties. As a result, we
have presented certain property information in this supplemental
presentation based on our pro rata ownership interest as of the
applicable date in properties included in these entities and not on
a consolidated basis. In such instances, information is noted as
being presented on a "pro-rata share" basis.
RevPOR: Revenue per occupied room. RevPOR is calculated
as total revenue generated by occupied rooms divided by the number
of occupied rooms.
RIDEA: used to describe properties within the portfolio
that utilize the RIDEA structure as described in "RIDEA
structure".
RIDEA structure: a structure permitted by the REIT
Investment Diversification and Empowerment Act of 2007, pursuant to
which we lease certain healthcare real estate properties to a
wholly-owned taxable REIT subsidiary (TRS), which in turn contracts
with an eligible independent contractor (EIK) to operate such
properties for a fee. Under this structure, the EIK receives
management fees, and the TRS receives revenue from the operation of
the healthcare real estate properties and retains, as profit, any
revenue remaining after payment of expenses (including intercompany
rent paid to us and any taxes at the TRS level) necessary to
operate the property. Through the RIDEA structure, in addition to
receiving rental revenue from the TRS, we retain any after-tax
profit from the operation of the healthcare real estate properties
and benefit from any improved operational performance while bearing
the risk of any decline in operating performance at the
properties.
Same-Store or SS: Properties owned and consolidated the
full period in both comparison periods and that are not otherwise
excluded. Properties are excluded from same-store if they are: (1)
sold, classified as held for sale or properties whose operations
were classified as discontinued operations in accordance with GAAP;
(2) impacted by materially disruptive events such as flood or fire
for an extensive period of time; or (3) and properties that are
scheduled to undergo major expansions/renovation, business model
transitions, or have transitioned business models after the start
of the prior comparison period.
Same-Store NOI or SS NOI: is defined as Cash NOI for
our Same-Store properties. Same-Store NOI is used to evaluate the
operating performance of our properties using a consistent
population which controls for changes in the composition of our
portfolio. Both Cash NOI and Same-Store NOI include ownership and
other adjustments.
Senior Housing-Leased: Senior housing facilities cater to
different segments of the elderly population based upon their
personal needs, and include assisted living, memory care, and
independent living. Residents of assisted living facilities
typically require limited medical care and need assistance with
eating, bathing, dressing, and/or medication management and those
services can be provided by staff at the facility. Resident
programs offered at such facilities may include transportation,
social activities, and exercise and fitness programs. Our Senior
Housing-Leased properties are triple-net leased.
SHOP: senior housing operating properties.
SNFs: skilled nursing facilities.
SOFR: The Secured Overnight Financing Rate (SOFR) is a
broad measure of the cost of borrowing cash overnight
collateralized by Treasury securities. SOFR as it relates to the
Company is used as the benchmark rate for its floating-rate debt
obligations.
Square Feet or Sq. Ft.: Net rentable square feet calculated
utilizing Building Owners and Managers Association measurement
standards.
Total Debt: The principal balances of the Company's
revolving credit facility, term loans, and secured indebtedness as
reported in the Company's consolidated financial statements.
Trilogy: Trilogy Investors, LLC, one of our
consolidated joint ventures, in which we indirectly owned a 74.1%
interest as of December 31, 2023.
Triple-net leased: a lease where the tenant is
responsible for making rent payments, maintaining the leased
property and paying property taxes and other expenses.
Yield on cost: annualized in-place Cash NOI or EBITDAR
divided by the aggregate investment cost and any debt being
assumed.
Contact: Alan
Peterson
Email:
investorrelations@ahcreit.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/american-healthcare-reit-ahr-announces-fourth-quarter-2023-and-full-year-2023-results-issues-full-year-2024-guidance-302096439.html
SOURCE American Healthcare REIT, Inc.